GentriBIO Inc. is pursuing growth as a leading company in the biotechnology field with the aim of realizing the best satisfaction for customer’s needs. GentriBIO estabilished as a bio-venture company, is researching for new drug discovery sucha as the biosimilar and oral medicines for diabetes treatment. Also, we are developing of in vitro diagnostic products to diagnosis the various disease such as virus infection including COVID-19, and norovirus, cancer, and harmful bacteria in human skins.